I Want To...
I Want To...
Find Research Faculty
Enter the last name, specialty or keyword for your search below.
School of Medicine
I Want to...
Renowned Leader in Nephrology and Johns Hopkins Division Director to be Awarded with New Professorship - 02/28/2012
Renowned Leader in Nephrology and Johns Hopkins Division Director to be Awarded with New Professorship
Release Date: February 28, 2012
Paul J. Scheel, Jr., M.D., M.B.A., associate professor at the Johns Hopkins University School of Medicine, will be named the inaugural Ronald R. Peterson Professor in Nephrology at the School of Medicine during a dedication ceremony on Thursday, March 1.
“Endowing a professorship provides the stability and flexibility needed for our faculty to improve the overall quality of a specific department,” says Edward D. Miller, M.D., dean and CEO of Johns Hopkins Medicine. “The endowment will provide Dr. Scheel the resources necessary to take advantage of the important opportunities for innovation, research and treatment of patients.”
The endowed professorship is named in honor of Ronald R. Peterson, president of The Johns Hopkins Hospital and Health System and executive vice president of Johns Hopkins Medicine.
“Dr. Scheel is a superb clinician and innovative program builder, a devoted and accomplished teacher and an internationally recognized investigator in his field,” Peterson says. “I am particularly honored for him to become the first recipient of this new professorship. “
Scheel, who came to Hopkins from Georgetown University Medical Center, is the director of the Division of Nephrology at The Johns Hopkins Hospital and Johns Hopkins Bayview Medical Center. After completing an internship and a residency in internal medicine and then a fellowship in nephrology, he joined the Hopkins faculty in 1992 and rose to the rank of director of the division by 2004.
Renowned for his expertise in the care of patients with renal disease, Scheel is responsible for developing medical therapy to treat patients with a rare disorder, retroperitoneal fibrosis. The therapy, developed by Dr. Scheel, is used by physicians throughout the world and eliminates the need for surgery or chronic indwelling ureteral stents.
“I am truly grateful for this endowment as it will enable our division to continue our fight to understand how autoimmune disorders work,” says Scheel. “Only by understanding the mechanisms of immunologic and autoimmune disorders can we determine the best approach for treatment, management and, ultimately, prevention of kidney diseases.”
The Johns Hopkins Division of Nephrology http://www.hopkinsmedicine.org/nephrology/
Ronald R. Peterson is president of The Johns Hopkins Hospital and Health System, and executive vice president of Johns Hopkins Medicine
For the Media
Media Contact: John M. Lazarou